Vials and Ampoules Market Intelligence

Vials and Ampoules Market Description

The global market for vials and ampoules is expected to grow at a CAGR of 6 to 7 percent to reach $12.4 billion in 2021. The market will be driven by the increasing consumption of vaccines, biopharmaceuticals, and insulin, particularly in emerging markets. The growing consumption parenteral packaging would also lead suppliers to expand their manufacturing facilities in countries such as Thailand, China, Malaysia, India, etc. over the next five years. Market share of plastic vials is 10 to 15 percent of the overall vials, owing to a large number of parenteral drugs being registered with the regulatory authorities.

Countries such as Canada, U.S., Germany, UK, France, Switzerland, Japan, Spain, and Italy are the most prominent production locations in developed regions, whereas Mexico, Colombia, Brazil, Argentina, Turkey, Pakistan, China, India, and Malaysia drive production in developing regions. The report also provides the value chain analysis of vials and ampoules, followed by an analysis of downstream demand. It also discusses various drivers and constraints driving change in the industry, followed by Porter’s five forces analysis of developed and emerging regions.

Beroe gathers intelligence through primary sources that include industry experts, researchers, and consultants, as well as current suppliers, producers and distributors. Secondary sources can include business journals, newsletters, magazines, market research data, company sources, and industry associations. Following data collation, analysis, and strategic review, the Final Research Report is published on Beroe LiVE.

Report Coverage

Market Trends
Technology & Innovation Trends
Global Supplier List and Capabilities
Mergers and Acquisitions

Vials and Ampoules Market Trend, Analysis & Forecast

Category Intelligence on Vials and Ampoules covers the following

Information relating to market, supply, cost, and pricing analysis
Hard to find data on cost and TCO models, supplier details, and performance benchmarks
Macroeconomic and regional trends impacting cost, supply, and other market dynamics
Category-specific negotiation and sourcing advice

icon
Executive Summary

icon
Market Analysis

icon
Supply Analysis

icon
Cost & Pricing Analysis

icon
Best Practices

1. Vials and Ampoules Executive Summary

1.1 Executive Summary

2. Vials and Ampoules Market Analysis

2.1 Value Chain Analysis
2.2 Global Market Outlook
– Current Market Size
– Demand–Supply Trends and Forecast
– Key End-use Industries
– Trade Dynamics
2.3 Regional Market Outlook (North America, EU, APAC, South America)
– Current Market Size
– Demand–Supply Trends and Forecast
– Trade Dynamics

3. Vials and Ampoules Industry Analysis

3.1 Industry Outlook (North America, EU, APAC, South America)
– Drivers and Constraints for the Industry
– Mergers & Acquisitions
– Innovations
– SWOT Analysis
– Porter’s Five Forces Analysis

4. Vials and Ampoules Cost Analysis

4.1 Cost Model for Glass Vials and Ampoules

5. Vials and Ampoules Supplier Analysis

5.1 Mergers and Acquisitions
5.2 Capacity Expansions
5.3 Supplier Market Share: Global
5.4 Key Global and Regional Suppliers
5.5 Key Supplier’s Capability Analysis
– Product Portfolio
5.6 Detailed Supplier Profiling of Top Global Suppliers
– SWOT Analysis for the Top Three Global Suppliers
– Financial Risk for Top Global Suppliers (if publicly listed)

Global Market Outlook on Vials and Ampoules

The global vials and ampoules market is expected to grow at 6–7 percent CAGR in 2017–2021 to reach $12.4 billion, driven by the increasing consumption of vaccines, biopharmaceuticals, and insulin, especially in the emerging markets

vials-and-ampoules-market-size

Regional Demand Overview

The growing consumption of parenteral packaging in the emerging markets would led the suppliers to expand their manufacturing facilities in countries, such as Thailand, China, Malaysia, India, etc., over the next five years

Global Market Size: Parenteral Containers

The global demand for parenteral packaging, which is forecasted at 9 – 10 percent CAGR in 2017 – 2021, would be largely driven by increasing prevalence of chronic diseases, growing geriatric population, and the preference for injection-based treatments. Additionally, the shift in preference for packaging material from glass to plastics would also influence value growth.
The global parenteral packaging market is driven by the growing complexity of drugs, fostered by increasing lifestyle diseases, increasing health awareness, and aging population. The emerging region is expected to contribute to a major portion of growth, with a CAGR of over 10 percent in 2017–2021
The key end-use segments are insulin, biopharmaceutical, and vaccines, which expected a strong demand of over 10 percent CAGR, facilitating growth. APAC and LATAM are expected to grow at a CARG of 13–14 percent from 2017 to 2021, owing to and rising demand for injectable drugs in these regions
Ampoules and vials are the largest segments in parenteral packaging, contributing to over 70 percent. However, the market is being penetrated by prefilled syringes, which is growing at a CAGR of 13–14 percent (2017– 2021). Advancements in delivery devices, like auto injectors, are also gaining main stage in parenteral delivery

Global Market Size: Vials and Ampoules

Growing complexity of drugs and increasing lifestyle diseases, like diabetes, are likely to foster growth in vials and ampoules, driven by rapid consumption from the emerging markets, like India and China.
The global vials and ampoules market is expected to grow at a CAGR of ~6–7 percent from 2017 to 2021, majorly driven by the increasing consumption of vaccines, biopharmaceuticals, and insulin, especially in the emerging markets
Vials and ampoules is the largest segment in parenteral packaging. The global pharma trend of increasing focus towards biopharmaceuticals is expected to facilitate sustained vials and ampoules demand over the next five years until 2021
More than 80 percent of the vials and ampoules are in glass format, owing to its suitability with varied drug combination, but faces challenges like delamination, breakage, etc. Alternative plastic vial options, like COP, COC formats, are likely to gain significant market share in the next five years

Buy Report ( ~~$999~~ $799)

Talk to sales

Download Sample